General form of registration statement for all companies including face-amount certificate companies

REVENUE

v3.24.1.1.u2
REVENUE
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Revenue from Contract with Customer [Abstract]    
REVENUE

4. REVENUE

The Company disaggregates revenue between continuing operations and discontinued operations. Revenue streams from contracts with customers depicts the nature, amount, timing and uncertainty of its revenue and cash flows as affected by economic factors. Commercial insurance consists of neuromonitoring cases whereby a patient has healthcare insurance that we bill. Facility billing consists of neuromonitoring cases whereby the Company has an agreement to bill the medical facility for patients that do not have health care insurance.

The Company does not have any contract assets or contract liabilities as of or during the three months ended March 31, 2024 or 2023 or as of December 31, 2023.

The Company’s revenue is as follows (in thousands):

    

Three Months Ended March 31, 

2024

    

2023

Managed service agreements and other

$

9

$

115

Accounts Receivable

A summary of the accounts receivable, net, by revenue stream is as follows (in thousands):

March 31, 

December 31,

    

2024

    

2023

Technical service

$

752

 

$

1,308

Professional service

1,191

2,293

Other

 

122

 

Total receivables, net

$

2,065

$

3,601

The concentration of accounts receivable, net, by payor as a percentage of total accounts receivable is as follows:

    

As of March 31,

As of December 31,

2024

    

2023

Commercial insurance

68

%

82

%

Facility billing

26

%

18

%

Other

6

%

%

Total

 

100

%

100

%

4. REVENUE

The Company disaggregates revenue from contracts with customers by revenue stream as this depicts the nature, amount, timing and uncertainty of its revenue and cash flows as affected by economic factors. Commercial insurance consists of all Neuromonitoring cases whereby a patient has healthcare insurance. Facility billing consists of services related to uninsured or government patients whereby the Company has an agreement with the facility for services for the patient and other contracted agreements with facilities.

The Company does not have any contract assets or contract liabilities as of or during the years ended December 31, 2023 and 2022.

The Company’s revenue disaggregated by payor is as follows (stated in thousands):

    

Year Ended December 31, 

2023

    

2022

  

 

  

Managed service agreements and other

$

255

$

471

Accounts Receivable

A summary of the accounts receivable by revenue stream is as follows (stated in thousands):

December 31, 

December 31,

December 31,

    

2023

    

2022

    

2021

Technical service

$

1,308

 

$

3,072

 

$

18,904

Professional service

2,293

11,829

8,209

Other

 

 

242

 

697

Total accounts receivable, net

3,601

15,143

27,810

Due from MSA

4,913

5,886

Total receivables, net

$

3,601

$

20,056

$

33,696

The concentration of accounts receivable by payor as a percentage of total accounts receivable is as follows:

As of December 31,

As of December 31,

    

2023

    

2022

  

Commercial insurance

82

%

84

%

Facility billing

18

%

9

%

Other

%

7

%

Total

 

100

%

100

%